US Food and Drug Administration to Study Blockchain Healthcare Applications
The US Food and Drug Administration (FDA), the government agency responsible for approving and regulating medical products, announced today its intent to study blockchain tech. Revealed in press materials published by IBM Watson Health, the research initiative will find the FDA teaming with IBM to explore how data from electronic medical records, clinical trials and health data from wearable devices could be better shared and audited using a blockchain. Initial tests will focus on clinical trials and real-world evidence data related to oncological data, according to the statements.....
Related News
The US Food and Drug Administration (FDA) is partnering IBM to research blockchain technology applications toward the exchange of health data. Revealed in an announcement yesterday by IBM Watson Health, the US federal agency is looking at ways in which health data be shared from medical devices and wearables, clinical trials and data from mobile devices. An initial focus will be dedicated to oncology-related data, the press release by IBM added. The joint-initiative will last two years until early 2019 and initial research findings are expected to be revealed this year. Blockchain’s....
The startup at the heart of a healthcare-focused blockchain consortium has raised $1.85m. The funding round for Hashed Health was led by Martin Ventures, an existing investor. Blockchain VC firm Fenbushi Capital, along with a group of private investors and relatives of the management team, also took part in the round. In statements, Hashed Health’s backers positioned the new funding as a way for the consortium to advance its work. Charles Martin, chairman and founder of Martin Ventures, said of the round: “The healthcare industry must be drastically reformed in order to address problems....
Today, IBM Watson Health has announced a collaborative project with the U.S. Food and Drug Administration aimed at applying emerging blockchain technology applications toward the advancement of public health. Through the use of blockchain technology, this project will explore efficient and secure ways for consumers to share their data and make better, more informed healthcare choices. This two-year research agreement will allow IBM and the FDA to explore ways of exchanging patient-level data from a number of different sources, including electronic medical records, clinical trials and....
Implementing artificial intelligence and blockchain technology into healthcare and medicine is key to unlocking human longevity. In the past 60 years, the life expectancy of the average newborn has increased by nearly 20 years — from 52.5 to 72, as of 2018. We’ve seen an incredible wave of technological innovation in this time: The introduction of the internet, medical breakthroughs and an enhanced understanding of public health initiatives have transformed the course of human life. And with new technologies like blockchain and artificial intelligence now taking the stage, we know that....
Blockchain tech specialist Gem officially launched Gem Health today, an initiative aimed at promoting collaboration in the healthcare space centered on the emerging technology. As part of the announcement, Gem unveiled its first partner on the effort, Philips, which will assist Gem as it seeks to build out a private Ethereum blockchain for use in the development of enterprise healthcare applications. In interview, Gem CEO Micah Winkelspecht described the effort as a way to encourage the healthcare industry to explore the potential benefits blockchain could have in the creation of wellness....